0001944048-23-000066.txt : 20230825
0001944048-23-000066.hdr.sgml : 20230825
20230825183820
ACCESSION NUMBER: 0001944048-23-000066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230823
FILED AS OF DATE: 20230825
DATE AS OF CHANGE: 20230825
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Xie Bing
CENTRAL INDEX KEY: 0001967716
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41697
FILM NUMBER: 231209684
MAIL ADDRESS:
STREET 1: 199 GRANDVIEW ROAD
CITY: SKILLMAN
STATE: NJ
ZIP: 08558
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kenvue Inc.
CENTRAL INDEX KEY: 0001944048
STANDARD INDUSTRIAL CLASSIFICATION: PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS [2844]
IRS NUMBER: 881032011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 199 GRANDVIEW ROAD
CITY: SKILLMAN
STATE: NJ
ZIP: 08558
BUSINESS PHONE: 908-874-1200
MAIL ADDRESS:
STREET 1: 199 GRANDVIEW ROAD
CITY: SKILLMAN
STATE: NJ
ZIP: 08558
FORMER COMPANY:
FORMER CONFORMED NAME: JNTL, Inc.
DATE OF NAME CHANGE: 20220825
4
1
wk-form4_1693003089.xml
FORM 4
X0508
4
2023-08-23
0
0001944048
Kenvue Inc.
KVUE
0001967716
Xie Bing
199 GRANDVIEW ROAD
SKILLMAN
NJ
08558
0
1
0
0
Group President APAC
0
Restricted Stock Units
2023-08-23
4
A
0
12386
0
A
Common Stock
12386
12386
D
Restricted Stock Units
2023-08-23
4
A
0
11520
0
A
Common Stock
11520
11520
D
Restricted Stock Units
2023-08-23
4
A
0
9016
0
A
Common Stock
9016
9016
D
Restricted Stock Units
2023-08-23
4
A
0
31885
0
A
Common Stock
31885
31885
D
Restricted Stock Units
2023-08-23
4
A
0
28803
0
A
Common Stock
28803
28803
D
Restricted Stock Units
2023-08-23
4
A
0
28781
0
A
Common Stock
28781
28781
D
Stock Options
21.97
2023-08-23
4
A
0
102484
0
A
2033-02-13
Common Stock
102484
102484
D
Stock Options
22.40
2023-08-23
4
A
0
113797
0
A
2032-02-14
Common Stock
113797
113797
D
Stock Options
22.23
2023-08-23
4
A
0
98988
0
A
2031-02-08
Common Stock
98988
98988
D
Stock Options
20.44
2023-08-23
4
A
0
86594
0
A
2030-02-10
Common Stock
86594
86594
D
Stock Options
17.82
2023-08-23
4
A
0
56168
0
A
2029-02-11
Common Stock
56168
56168
D
Stock Options
17.49
2023-08-23
4
A
0
42263
0
A
2028-02-12
Common Stock
42263
42263
D
Stock Options
15.62
2023-08-23
4
A
0
42552
0
A
2027-02-13
Common Stock
42552
42552
D
These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through the vesting date.
This award will vest in full on 02/14/2025, subject to the reporting person's continued service through the vesting date.
This award will vest in full on 02/08/2024, subject to the reporting person's continued service through the vesting date.
These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
This award will vest in full on 02/13/2026, subject to the reporting person's continued service through the vesting date.
These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.
This award is fully vested.
/s/ Alla Berenshteyn, as attorney-in-fact
2023-08-25